Stay updated on Alteplase in Mild Stroke: Efficacy Clinical Trial
Sign up to get notified when there's something new on the Alteplase in Mild Stroke: Efficacy Clinical Trial page.

Latest updates to the Alteplase in Mild Stroke: Efficacy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a new revision tag: Revision: v3.4.2. The maintenance notices were removed, including the lapsed funding notice and the previous Revision: v3.4.1 entry.SummaryDifference0.2%

- Check21 days agoChange DetectedAdded a government funding notice and the revision tag v3.4.1; removed the previous revision tag v3.4.0.SummaryDifference0.2%

- Check28 days agoChange DetectedAdded a Show glossary option and updated the revision to v3.4.0. The QC-related field label was capitalized ('Last Update Submitted that Met QC Criteria') and the 'No FEAR Act Data' wording was adjusted.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 with no visible changes to study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a comprehensive list of study locations by state (Alabama, Arizona, California, etc.) and updated to Revision: v3.3.3, replacing the previous v3.3.2 location data.SummaryDifference2%

- Check85 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. The update does not change study details or page content.SummaryDifference0.0%

Stay in the know with updates to Alteplase in Mild Stroke: Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alteplase in Mild Stroke: Efficacy Clinical Trial page.